Pages that link to "Q37514259"

The following pages link to Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update (Q37514259):

Displaying 43 items.

• "Stormy waters ahead": global emergence of carbapenemases (Q21131125) (← links)
• New treatment options against gram-negative organisms (Q21194906) (← links)
• Kinetics of avibactam inhibition against Class A, C, and D β-lactamases (Q24617763) (← links)
• Carbapenems: past, present, and future (Q24634999) (← links)
• The Chemical Biology of Human Metallo-β-Lactamase Fold Proteins (Q26775167) (← links)
• Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712 (Q27670446) (← links)
• Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus (Q28543476) (← links)
• Q&A: Antibiotic resistance: where does it come from and what can we do about it? (Q33708183) (← links)
• Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes (Q34589777) (← links)
• An altered zinc-binding site confers resistance to a covalent inactivator of New Delhi metallo-beta-lactamase-1 (NDM-1) discovered by high-throughput screening (Q34671008) (← links)
• Identification of Products of Inhibition of GES-2 β-Lactamase by Tazobactam by X-ray Crystallography and Spectrometry (Q34800304) (← links)
• Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases. (Q34932937) (← links)
• In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study) (Q35004966) (← links)
• Prediction of resistance development against drug combinations by collateral responses to component drugs (Q35854877) (← links)
• Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance (Q37735903) (← links)
• Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa (Q37756180) (← links)
• New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance (Q37767653) (← links)
• The future of the β-lactams. (Q37796156) (← links)
• Emerging carbapenemases: a global perspective (Q37815629) (← links)
• Engineering antibiotic production and overcoming bacterial resistance (Q37887690) (← links)
• Drug Repositioning in the Treatment of Malaria and TB (Q37924298) (← links)
• Will new antimicrobials overcome resistance among Gram-negatives? (Q37942654) (← links)
• Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns (Q38001333) (← links)
• New antibiotics for bad bugs: where are we? (Q38132217) (← links)
• Characterization of a highly efficient antibiotic-degrading metallo-β-lactamase obtained from an uncultured member of a permafrost community. (Q38657836) (← links)
• The contribution of antibiotics, pneumonia and the immune response to stroke outcome. (Q39729591) (← links)
• In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013. (Q41240109) (← links)
• Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor (Q42046174) (← links)
• Structural studies on New Delhi Metallo-β-lactamase (NDM-2) suggest old β-lactam, penicillin to be better antibiotic for NDM-2-harbouring Acinetobacter baumanni (Q44099218) (← links)
• Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations (Q46243175) (← links)
• OXA-48-like carbapenemases producing Enterobacteriaceae in different niches (Q46291390) (← links)
• Conformational stability of OXA-51 β-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii (Q47952651) (← links)
• Shift of uterine microbiota associated with antibiotic treatment and cure of metritis in dairy cows. (Q50058784) (← links)
• 4D-QSAR analysis and pharmacophore modeling: Electron conformational-genetic algorithm approach for penicillins (Q51589595) (← links)
• blaCTX-M, blaTEM, and blaSHV in Enterobacteriaceae from North-Indian tertiary hospital: high occurrence of combination genes (Q54356781) (← links)
• Highly Prevalent Multidrug-Resistant From Chicken and Pork Meat at Retail Markets in Guangdong, China (Q58753972) (← links)
• Factors Contributing to the Evolution of -Mediated β-lactam Resistance in Staphylococci: Update and New Insights From Whole Genome Sequencing (WGS) (Q59335521) (← links)
• Substrate Specificity of Low-Molecular Mass Bacterial dd-Peptidases (Q82216837) (← links)
• Occurrence and molecular epidemiology of blaCTX-M, including co-occurrence of blaTEM and blaSHV genes, and sul1 association in Indian Enterobacteriaceae (Q83094224) (← links)
• In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics (Q83310118) (← links)
• Increasing secondary bacterial infections with Enterobacteriaceae harboring blaCTX–M–15 and blaCMY-6 in patients with bronchogenic carcinoma: an emerging point of concern (Q84575734) (← links)
• Ecology and evolution of antimicrobial resistance in bacterial communities (Q102220377) (← links)
• Chemoinformatics-based enumeration of chemical libraries: a tutorial (Q106600475) (← links)